ALung, now part of LivaNova, is a leading medical technology company based in Pittsburgh, PA. They have developed the HEMOLUNG System, the first and only FDA cleared extracorporeal CO2 removal device, which removes carbon dioxide directly from the blood, allowing the lungs to rest and heal. The HEMOLUNG offers an integrated solution for acute respiratory failure, providing clinical benefits such as correcting hypercapnia and respiratory acidosis, potentially avoiding invasive mechanical ventilation. With over 1000 patient treatments for acute respiratory failure, the HEMOLUNG is designed to be used in a variety of hospital settings, even those without specialized extracorporeal lung support experience. ALung's dedicated team of clinical specialists and engineers provide sales support, on-site training, 24/7 on-call support, and device installation and service. The HEMOLUNG is indicated for adults with acute, reversible respiratory failure who cannot achieve adequate or safe CO2 ventilation using other treatment options and are expected to experience continued clinical deterioration.Generated from the website